REPLICEL LIFE SCIENCES INC.

(REPCF)
Delayed OTC Markets  -  11:56 2022-06-24 am EDT
0.1005 USD   +16.59%
06/17REPLICEL LIFE SCIENCES : PROVIDES DEFAULT STATUS UPDATE - Form 6-K
PU
06/02REPLICEL LIFE SCIENCES : PROVIDES DEFAULT STATUS UPDATE - Form 6-K
PU
03/29REPLICEL LIFE SCIENCES : 51-102F3 MATERIAL CHANGE REPORT - Form 6-K
PU
SummaryQuotesChartsNewsCalendarCompanyFinancials 
Valuation
Fiscal Period: December 2015 2016 2017 2018 2019 2020
Capitalization1 16,914,28,409,658,747,26
Enterprise Value (EV)1 16,914,28,409,659,147,80
P/E ratio -3,01x-1,78x-1,21x-2,83x-2,29x-3,69x
Yield ------
Capitalization / Revenue ---57 561 954x24 719 357x20 516 305x
EV / Revenue ---57 561 954x24 719 358x20 516 306x
EV / EBITDA -3,36x-3,33x-1,40x-3,58x-2,99x-5,38x
Price to Book -----1,59x-1,28x
Nbr of stocks (in thousands) 6 34814 93821 54326 80030 64633 523
Reference price (CAD) 2,670,950,390,360,290,22
Announcement Date 04/30/201804/30/201912/22/202004/30/202104/30/202104/30/2021
1 USD in Million
Income Statement Evolution (Annual data)
Fiscal Period: December 2015 2016 2017 2018 2019 2020
Net sales ---0,170,350,35
EBITDA1 -5,04-4,28-5,99-2,69-2,92-1,35
Operating profit (EBIT)1 -5,05-4,29-5,99-2,70-2,93-1,35
Operating Margin ----1 609%-827%-382%
Pre-Tax Profit (EBT)1 -5,04-4,27-6,01-2,78-3,00-1,58
Net income1 -5,04-4,27-6,01-2,78-3,00-1,58
Net margin ----1 660%-849%-447%
EPS2 -0,89-0,54-0,32-0,13-0,12-0,06
Dividend per Share ------
Announcement Date 04/30/201804/30/201912/22/202004/30/202104/30/202104/30/2021
1 CAD in Million
2 CAD
Balance Sheet Analysis
Fiscal Period: December 2015 2016 2017 2018 2019 2020
Net Debt ----0,400,54
Net Cash position ------
Leverage (Debt / EBITDA) -----0,14x-0,40x
Free Cash Flow1 -2,47-1,99-3,12-1,15-1,94-0,26
ROE (Net Profit / Equities) -838%-1 413%-1 357%251%95,0%33,3%
Shareholders' equity1 0,600,300,44-1,11-3,16-4,74
ROA (Net Profit / Asset) -247%-239%-280%-80,9%-95,5%-182%
Assets1 2,041,792,153,443,140,87
Book Value Per Share -----0,18-0,17
Cash Flow per Share ----0,000,00
Capex1 0,00-----
Capex / Sales ------
Announcement Date 04/30/201804/30/201912/22/202004/30/202104/30/202104/30/2021
1 CAD in Million
Key data
Capitalization (USD) 4 696 993
Net sales (CAD) 353 735
Net sales (USD) 273 852
Number of employees 1
Sales / Employee (CAD) 353 735
Sales / Employee (USD) 273 852
Free-Float 62,3%
Free-Float capitalization (USD) 2 926 181
Avg. Exchange 20 sessions (CAD) 209
Avg. Exchange 20 sessions (USD) 162
Average Daily Capital Traded 0,00%
EPS & Dividend